198 related articles for article (PubMed ID: 16331249)
1. Androgen receptor levels are increased by interferons in human prostate stromal and epithelial cells.
Basrawala Z; Alimirah F; Xin H; Mohideen N; Campbell SC; Flanigan RC; Choubey D
Oncogene; 2006 May; 25(19):2812-7. PubMed ID: 16331249
[TBL] [Abstract][Full Text] [Related]
2. Stromal-epithelial cell interactions and androgen receptor-coregulator recruitment is altered in the tissue microenvironment of prostate cancer.
Cano P; Godoy A; Escamilla R; Dhir R; Onate SA
Cancer Res; 2007 Jan; 67(2):511-9. PubMed ID: 17234758
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor levels in prostate cancer epithelial and peritumoral stromal cells identify non-organ confined disease.
Ricciardelli C; Choong CS; Buchanan G; Vivekanandan S; Neufing P; Stahl J; Marshall VR; Horsfall DJ; Tilley WD
Prostate; 2005 Apr; 63(1):19-28. PubMed ID: 15378523
[TBL] [Abstract][Full Text] [Related]
4. Effect of increasing ratio of estrogen: androgen on proliferation of normal human prostate stromal and epithelial cells, and the malignant cell line LNCaP.
King KJ; Nicholson HD; Assinder SJ
Prostate; 2006 Jan; 66(1):105-14. PubMed ID: 16114065
[TBL] [Abstract][Full Text] [Related]
5. Hic-5/ARA55, a LIM domain-containing nuclear receptor coactivator expressed in prostate stromal cells.
Heitzer MD; DeFranco DB
Cancer Res; 2006 Jul; 66(14):7326-33. PubMed ID: 16849583
[TBL] [Abstract][Full Text] [Related]
6. Prosaposin is an AR-target gene and its neurotrophic domain upregulates AR expression and activity in prostate stromal cells.
Koochekpour S; Lee TJ; Sun Y; Hu S; Grabowski GA; Liu Z; Garay J
J Cell Biochem; 2008 Aug; 104(6):2272-85. PubMed ID: 18481277
[TBL] [Abstract][Full Text] [Related]
7. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.
Ramberg H; Eide T; Krobert KA; Levy FO; Dizeyi N; Bjartell AS; Abrahamsson PA; Taskén KA
Prostate; 2008 Jul; 68(10):1133-42. PubMed ID: 18454446
[TBL] [Abstract][Full Text] [Related]
8. Androgen sensitivity of prostate epithelium is enhanced by postnatal androgen receptor inactivation.
Simanainen U; McNamara K; Gao YR; Handelsman DJ
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1335-43. PubMed ID: 19366880
[TBL] [Abstract][Full Text] [Related]
9. Androgen and prostatic stroma.
Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
[TBL] [Abstract][Full Text] [Related]
10. SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells.
Wang H; McKnight NC; Zhang T; Lu ML; Balk SP; Yuan X
Cancer Res; 2007 Jan; 67(2):528-36. PubMed ID: 17234760
[TBL] [Abstract][Full Text] [Related]
11. Nuclear androgen receptors recur in the epithelial and stromal compartments of malignant and non-malignant human prostate tissue several months after castration therapy.
Wikström P; Ohlson N; Stattin P; Bergh A
Prostate; 2007 Sep; 67(12):1277-84. PubMed ID: 17597113
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor modulation in benign human prostatic tissue and prostatic adenocarcinoma during neoadjuvant endocrine combination therapy.
Van der Kwast TH; Têtu B; Fradet Y; Dupont A; Gomez J; Cusan L; Diamond P; Labrie F
Prostate; 1996 Apr; 28(4):227-31. PubMed ID: 8602398
[TBL] [Abstract][Full Text] [Related]
13. Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor.
Wu CT; Altuwaijri S; Ricke WA; Huang SP; Yeh S; Zhang C; Niu Y; Tsai MY; Chang C
Proc Natl Acad Sci U S A; 2007 Jul; 104(31):12679-84. PubMed ID: 17652515
[TBL] [Abstract][Full Text] [Related]
14. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells.
Gao J; Arnold JT; Isaacs JT
Cancer Res; 2001 Jul; 61(13):5038-44. PubMed ID: 11431338
[TBL] [Abstract][Full Text] [Related]
15. Suppression of androgen receptor expression by dibenzoylmethane as a therapeutic objective in advanced prostate cancer.
Jackson KM; Frazier MC; Harris WB
Anticancer Res; 2007; 27(3B):1483-8. PubMed ID: 17595765
[TBL] [Abstract][Full Text] [Related]
16. Altered expression of androgen receptor in the malignant epithelium and adjacent stroma is associated with early relapse in prostate cancer.
Henshall SM; Quinn DI; Lee CS; Head DR; Golovsky D; Brenner PC; Delprado W; Stricker PD; Grygiel JJ; Sutherland RL
Cancer Res; 2001 Jan; 61(2):423-7. PubMed ID: 11212224
[TBL] [Abstract][Full Text] [Related]
17. cDNA microarray analysis identifies genes induced in common by peptide growth factors and androgen in human prostate epithelial cells.
York TP; Plymate SR; Nelson PS; Eaves LJ; Webb HD; Ware JL
Mol Carcinog; 2005 Dec; 44(4):242-51. PubMed ID: 16240454
[TBL] [Abstract][Full Text] [Related]
18. Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells.
Xie Y; Wolff DW; Lin MF; Tu Y
Mol Pharmacol; 2007 Jul; 72(1):73-85. PubMed ID: 17430995
[TBL] [Abstract][Full Text] [Related]
19. Role of IFI 16, a member of the interferon-inducible p200-protein family, in prostate epithelial cellular senescence.
Xin H; Curry J; Johnstone RW; Nickoloff BJ; Choubey D
Oncogene; 2003 Jul; 22(31):4831-40. PubMed ID: 12894224
[TBL] [Abstract][Full Text] [Related]
20. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms.
Tepper CG; Vinall RL; Wee CB; Xue L; Shi XB; Burich R; Mack PC; de Vere White RW
Prostate; 2007 Apr; 67(5):521-35. PubMed ID: 17252539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]